NewPort Communications
	Developer of high-performance optical communications chips. The Company\'s devices are based on a proprietary design technology called Current-Controlled CMOS (C3MOS(TM)).
	['', 'optical communication', ' ', 'communication chip', ' ', 'proprietary design technology', '']
Genetics Institute
	Developer of pharmaceutical products. The firm developed pharmaceuticals based on leading edge functional genomics technologies and proprietary disease models to treat a wide variety of human disease conditions.
	['biopharmaceuticals']
Shire Regenerative Medicine
	Developer of cell-based therapies. It develops Dermagraft, which received a premarket approval from the U.S. food and drug administration. Dermagraft is a regenerative bio-engineered skin substitute that assists in restoring damaged tissue and is indicated for the treatment of certain types of diabetic foot ulcers (DFU).
	['', 'cell based therapy', ' ', 'skin substitute', ' ', 'skin replacement product', '']
ULSD
	Researcher of oral biology as well as olecular, cellular and craniofacial biology with faculty members. The company\'s main objective is to enhance the speed to market the oral developments within the UofL School of Dentistry.
	['', 'cellular biology', ' ', 'dental hygiene', ' ', 'oral development', '']
Arizeke Pharmaceuticals
	Developer of technologies for oral delivery of macromolecules. The company\'s technology takes advantage of an active transport system, using the polymeric immunoglobulin receptor (pIgR) highly expressed in the intestinal and lung epithelium, and enables delivery of macromolecules such as therapeutic proteins and antibodies via oral or nasal administration.
	['', 'delivery system', '  macromolecules ', 'protein delivery', ' ', 'therapeutic proteins', ' ', 'active transport system', '']
Scandinavian BioPharma
	Developer of pharmaceutical  products such as vaccines and immunoglobulins. The company mainly focuses on development of a new oral traveler’s diarrhea vaccine. The company is currently developing a pharmaceutical  product for the treatment of mild to moderate psoriasis.
	['vaccines immunoglobins ', 'diarrhea vaccine', '']
E-Pill Pharma
	Provider of oral drug delivery products for healthcare markets. The company\'s product line includes an oral drug delivery platform which is a combination of medical device and tablets.
	['', 'medical devices', ' ', 'healthcare industry', '']
Benchmark Storage Innovations
	Developer of tape and storage automation devices. The company\'s products are based on DLT™tape technology and it delivers its products and services through various channels and strategic partners.
	['', 'storage automation', ' ', 'DLT tape technology', ' ', 'automation devices', ' ', 'tape storage', ' ', 'electronic parts', ' ', 'computer hardware', '']
Creatogen
	Developer of technology for genome wide functional genomics. The company develops bacterial carriers for oral delivery to treat and to prevent acute and chronic diseases caused by an imbalance of the immune system. The company also develops a bird flu vaccine for poultry.
	['genomics ', 'bacterial carriers', ' ', 'oral delivery', ' ', 'chronic diseases', ' ', 'immune system', ' ', 'bird flu vaccine', '']
Anesta
	Developer of pharmaceutical products for oral transmucosal drug administration. The Company\'s products are based on its proprietary oral transmucosal system (OTS) for drug delivery.
	['', 'oral transmucosal system', ' ', 'pharmaceutical product', ' ', 'oral transmucosal drug', '']
